Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Explorative and targeted neuroproteomics in Alzheimer's disease.

Brinkmalm A, Portelius E, Öhrfelt A, Brinkmalm G, Andreasson U, Gobom J, Blennow K, Zetterberg H.

Biochim Biophys Acta. 2015 Jan 22. pii: S1570-9639(15)00020-5. doi: 10.1016/j.bbapap.2015.01.009. [Epub ahead of print] Review.

PMID:
25619854
[PubMed - as supplied by publisher]
2.

Human cerebrospinal fluid increases the excitability of pyramidal neurons in the in vitro brain slice.

Bjorefeldt A, Andreasson U, Daborg J, Riebe I, Wasling P, Zetterberg H, Hanse E.

J Physiol. 2015 Jan 1;593(1):231-43. doi: 10.1113/jphysiol.2014.284711. Epub 2014 Nov 25.

PMID:
25556798
[PubMed - in process]
3.

Comment on "An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice".

Emilsson JF, Andreasson U, Blennow K, Eriksson E, Zetterberg H.

Sci Transl Med. 2014 Dec 24;6(268):268le5. doi: 10.1126/scitranslmed.3010053. No abstract available.

PMID:
25540322
[PubMed - in process]
4.

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.

Kvartsberg H, Duits FH, Ingelsson M, Andreasen N, Öhrfelt A, Andersson K, Brinkmalm G, Lannfelt L, Minthon L, Hansson O, Andreasson U, Teunissen CE, Scheltens P, Van der Flier WM, Zetterberg H, Portelius E, Blennow K.

Alzheimers Dement. 2014 Dec 19. pii: S1552-5260(14)02863-5. doi: 10.1016/j.jalz.2014.10.009. [Epub ahead of print]

PMID:
25533203
[PubMed - as supplied by publisher]
5.

β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage.

Portelius E, Dean RA, Andreasson U, Mattsson N, Westerlund A, Olsson M, Demattos RB, Racke MM, Zetterberg H, May PC, Blennow K.

Alzheimers Res Ther. 2014 Nov 17;6(5-8):75. doi: 10.1186/s13195-014-0075-0. eCollection 2014.

PMID:
25404952
[PubMed]
Free PMC Article
6.

Human cerebrospinal fluid increases the excitability of pyramidal neurons in the in vitro brain slice.

Bjorefeldt A, Andreasson U, Daborg J, Riebe I, Wasling P, Zetterberg H, Hanse E.

J Physiol. 2014 Oct 31. [Epub ahead of print]

PMID:
25362155
[PubMed - as supplied by publisher]
7.

The Biobanking Analysis Resource Catalogue (BARCdb): a new research tool for the analysis of biobank samples.

Galli J, Oelrich J, Taussig MJ, Andreasson U, Ortega-Paino E, Landegren U.

Nucleic Acids Res. 2015 Jan 28;43(Database issue):D1158-62. doi: 10.1093/nar/gku1008. Epub 2014 Oct 21.

PMID:
25336620
[PubMed - in process]
Free Article
8.

Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease.

Rosén C, Andersson CH, Andreasson U, Molinuevo JL, Bjerke M, Rami L, Lladó A, Blennow K, Zetterberg H.

Dement Geriatr Cogn Dis Extra. 2014 Jul 31;4(2):297-304. doi: 10.1159/000362164. eCollection 2014 May.

PMID:
25254036
[PubMed]
Free PMC Article
9.

Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.

Lautner R, Palmqvist S, Mattsson N, Andreasson U, Wallin A, Pålsson E, Jakobsson J, Herukka SK, Owenius R, Olsson B, Hampel H, Rujescu D, Ewers M, Landén M, Minthon L, Blennow K, Zetterberg H, Hansson O; Alzheimer’s Disease Neuroimaging Initiative.

JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060.

PMID:
25162367
[PubMed - indexed for MEDLINE]
10.

Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography.

Palmqvist S, Zetterberg H, Blennow K, Vestberg S, Andreasson U, Brooks DJ, Owenius R, Hägerström D, Wollmer P, Minthon L, Hansson O.

JAMA Neurol. 2014 Oct;71(10):1282-9. doi: 10.1001/jamaneurol.2014.1358.

PMID:
25155658
[PubMed - in process]
11.

Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid.

Portelius E, Soininen H, Andreasson U, Zetterberg H, Persson R, Karlsson G, Blennow K, Herukka SK, Mattsson N.

Neurodegener Dis. 2014;14(2):98-106. doi: 10.1159/000358800. Epub 2014 Jun 27.

PMID:
24992945
[PubMed - in process]
12.

Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease.

Mielke MM, Haughey NJ, Bandaru VV, Zetterberg H, Blennow K, Andreasson U, Johnson SC, Gleason CE, Blazel HM, Puglielli L, Sager MA, Asthana S, Carlsson CM.

Neurobiol Aging. 2014 Nov;35(11):2486-94. doi: 10.1016/j.neurobiolaging.2014.05.019. Epub 2014 May 27.

PMID:
24952994
[PubMed - in process]
13.

Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluid.

Leinenbach A, Pannee J, Dülffer T, Huber A, Bittner T, Andreasson U, Gobom J, Zetterberg H, Kobold U, Portelius E, Blennow K; IFCC Scientific Division Working Group on CSF proteins.

Clin Chem. 2014 Jul;60(7):987-94. doi: 10.1373/clinchem.2013.220392. Epub 2014 May 19.

PMID:
24842955
[PubMed - indexed for MEDLINE]
14.

CSF Aβ42 predicts early-onset dementia in Parkinson disease.

Alves G, Lange J, Blennow K, Zetterberg H, Andreasson U, Førland MG, Tysnes OB, Larsen JP, Pedersen KF.

Neurology. 2014 May 20;82(20):1784-90. doi: 10.1212/WNL.0000000000000425. Epub 2014 Apr 18.

PMID:
24748671
[PubMed - indexed for MEDLINE]
15.

Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment.

Zetterberg H, Jakobsson J, Redsäter M, Andreasson U, Pålsson E, Ekman CJ, Sellgren C, Johansson AG, Blennow K, Landén M.

Psychiatry Res. 2014 Jul 30;217(3):143-6. doi: 10.1016/j.psychres.2014.03.045. Epub 2014 Apr 5.

PMID:
24745469
[PubMed - in process]
16.

CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.

Mondello S, Constantinescu R, Zetterberg H, Andreasson U, Holmberg B, Jeromin A.

Parkinsonism Relat Disord. 2014 Apr;20(4):382-7. doi: 10.1016/j.parkreldis.2014.01.011. Epub 2014 Jan 22.

PMID:
24507721
[PubMed - indexed for MEDLINE]
17.

Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease.

Johansson P, Almqvist EG, Johansson JO, Mattsson N, Andreasson U, Hansson O, Wallin A, Blennow K, Zetterberg H, Svensson J.

PLoS One. 2013 Nov 29;8(11):e81989. doi: 10.1371/journal.pone.0081989. eCollection 2013.

PMID:
24312390
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Cerebrospinal fluid biomarkers in cardiac arrest survivors.

Rosén C, Rosén H, Andreasson U, Bremell D, Bremler R, Hagberg L, Rosengren L, Blennow K, Zetterberg H.

Resuscitation. 2014 Feb;85(2):227-32. doi: 10.1016/j.resuscitation.2013.10.032. Epub 2013 Nov 11.

PMID:
24231570
[PubMed - indexed for MEDLINE]
19.

Lipopolysaccharide-induced inflammation aggravates irradiation-induced injury to the young mouse brain.

Roughton K, Andreasson U, Blomgren K, Kalm M.

Dev Neurosci. 2013;35(5):406-15. doi: 10.1159/000353820. Epub 2013 Aug 20.

PMID:
23970040
[PubMed - indexed for MEDLINE]
20.

Cerebrospinal fluid brain injury biomarkers in children: a multicenter study.

Shahim P, Darin N, Andreasson U, Blennow K, Jennions E, Lundgren J, Månsson JE, Naess K, Törnhage CJ, Zetterberg H, Mattsson N.

Pediatr Neurol. 2013 Jul;49(1):31-39.e2. doi: 10.1016/j.pediatrneurol.2013.02.015.

PMID:
23827424
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk